Salem, NC
Other
Updated 1 year ago

FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients With Anemia

Reporter: Everydayhealth

 FDA Approves Momelotinib (Ojjaara) for Myelofibrosis Patients With Anemia

Share your feelings about this article

Marvellous Icon Interaction animation marvellous Image

Marvellous00

Article Interaction Bullseye Image Interaction Animation Bullseye Image

Right on00

Article Interaction Good Image interaction animation good

Good00


A A+ A++ A+++
The U.S. Food and Drug Administration (FDA) has approved the first drug in a family of medicines known as JAK inhibitors that can treat myelofibrosis patient...

Go to original article source

Related : Kids need to go back to school

Salem, NC

1

Articles

0

Followers

0

Views

Overall Article Rating:
0.0
View Article Ratings
Contributions (0)
Add Contribution+2 pts.

A contribution is an additional perspective to the primary article. You may add your contribution to the article and it will be featured below the primary article. Each contribution will follow the article in order of date added.

Comment (0) Details Min. 25 characters required | (500 characters limit) This is the exciting part of article , add your valuable comment.
Add Comment+1 pt.
Salem, NC